Peter van der Velden MBA, MSC

Managing General Partner, Lumira Ventures

With 28 years of investment and operating experience, Peter has participated in building companies from start-up through to expansion in the life sciences, information technology, and consumer sectors. Known as a results-oriented entrepreneur with demonstrated success in venture and buyout investing, transaction structuring and completion, strategic planning, business development, and operational management and restructuring, Peter has established a strong reputation for leadership, consensus building, judgment, integrity, and clarity of vision.

Responsible for the overall business operations of Lumira Ventures, Peter is also active on the investment-side, focusing primarily on growth equity investments in companies that have made, or are close-to-making, the transition from development to selling and marketing their products. Peter’s specific investment expertise includes non-traditional and consumer-oriented medicines, spin-outs of operating businesses, restructurings, and public companies.

Peter is a very active volunteer in the communities in which he works and plays and is a frequent lecturer at universities and conferences around the world on themes related to venture capital, innovation, and healthcare. He works closely with Canada’s Federal and Provincial governments to advise on policy matters related to healthcare innovation and innovation financing. As the Chairman of the Canadian Venture Capital & Private Equity Association (CVCA), he worked closely with the Federal government on their Venture Capital Action Plan and was a member of the Government of Ontario’s Health Innovation Council, whose mission was to enhance the adoption of Ontario-based innovation by the Ontario healthcare system.

Peter Van Der Velden v1
Amacathera Logo

AmacaThera is a clinical-stage biotechnology company transforming therapeutics to make a difference in patient health. Our unique, injectable hydrogel platform provides localized, sustained drug delivery to improve patient outcomes across multiple therapeutic areas, including post‑surgical pain management, cancer and other hard‑to‑reach target areas.

Contact Us

MaRS Centre, West Tower,
661 University Ave Suite 1300,
Toronto, ON M5G 0B7

[email protected]